Baku 29° C
Azerbaijan starts applying AstraZeneca vaccine
Health
- 03 May, 2021
- 04:54
From May 3, Azerbaijan begins using the Vaxzevria vaccine produced by the University of Oxford (AstraZeneca manufacturer name) for vaccination against COVID-19 in the country (at the preliminary stage for people aged 60 and over), Report informs.
Vaxzevria vaccines will be used in the city of Baku and six regions - Lankaran, Sheki, Ganja, Mingachevir, Absheron and Sumgait.
The 84,000 doses of Vaxzevria vaccines delivered to Azerbaijan through the COVAX platform increase the possibility of choice for citizens and at the same time enhance the availability of vaccines for the population.
The Vaxzevria vaccine, developed by the Anglo-Swedish company AstraZeneca, was approved by the World Health Organization.
Author
Latest News
21:45
Ilham Aliyev: We are witnessing tangible dividends of peace in economic, trade and other spheres
Foreign policy21:37
Ilham Aliyev: TRIPP holds tremendous potential for ensuring security in South Caucasus
Foreign policy21:29
President: Azerbaijan–US ties have now reached their highest point in 34-year history of diplomatic relations
Foreign policy21:25
Ilham Aliyev: Azerbaijani society embracing peaceful environment that has emerged in the region
Foreign policy20:11
Work on transport infrastructure in Azerbaijan nearing completion as part of TRIPP
Foreign policy20:06
Donald Trump highly appreciates President Ilham Aliyev's role in peace process
Foreign policy19:58
Ilham Aliyev and Donald Trump hold telephone conversation
Foreign policy19:56
Witkoff: South Caucasus is safer, more prosperous and more stable
Region19:40